Previous studies linked refined grains intake to risk of gestational diabetes (GDM) ; however, the underlying mechanisms remain understudied. We aimed to identify and validate refined grains-related metabolites as biomarkers for GDM. In a nested case-control study of 91 women with GDM and 180 non-GDM controls (discovery set) in the Pregnancy Environment and Lifestyle Study (PETALS) cohort, we assessed dietary intake of refined grains by a validated food frequency questionnaire and measured fasting serum untargeted metabolomics at gestational weeks (GW) 10-13. We identified metabolites associated with refined grains intake using multivariable linear regression and examined prospective associations of refined grains-related metabolites at GW 10-13 with risk of GDM in later pregnancy using conditional logistic regression. We further examined incremental predictivity of refined grains-related metabolites selected by 10-fold cross-validated LASSO regression beyond conventional risk factors in the discovery set and a random PETALS subsample (38 GDM, 336 non-GDM) as the validation set. Among 821 known metabolites, 42 (mostly lipids/lipid-like molecules and organic oxygen/acids compounds) were associated with refined grains intake in early pregnancy, of which 17 were significantly associated with GDM risk (all FDR < 0.05) . Adding seven out of 17 metabolites selected by LASSO regression to a conventional risk factor-based prediction model increased the C-statistic from 0.71 (95% CI 0.64-0.77) to 0.77 (0.71-0.83) ; P-for-difference < 0.05. Similar improvement was observed in the validation set [0.77 (0.69-0.86) to 0.81 (0.74-0.89) ; P-for-difference < 0.05]. Refined grains intake may be associated with risk of GDM via perturbed metabolic pathways of glycerolipids, glycerophospholipids, and sphingolipids. Refined grains-related metabolites might help improve prediction of GDM risk and inform diet-related preventive strategies. Further validation studies are warranted.

Disclosure

Y.Zhu: None. S.Zheng: None. A.Ngo: None. R.F.Chehab: None. E.Z.Wang: None. O.Fiehn: None. A.Ferrara: n/a.

Funding

National Institutes of Health Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Program (K12HD052163) ; National Institute of Diabetes and Digestive and Kidney Diseases (K01DK120807)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.